Timothy P Stevens
Affiliation: University of Rochester
- Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT)Timothy P Stevens
Department of Pediatrics, University of Rochester Medical Center and Golisano Children s Hospital, Rochester, NY Electronic address
J Pediatr 165:240-249.e4. 2014....
- Evidence-based approach to preventing central line-associated bloodstream infection in the NICUTimothy P Stevens
Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA
Acta Paediatr Suppl 101:11-6. 2012..To review care practices and methods of implementation that reduce the risk of central line-associated bloodstream infection (CLABSI)...
- Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasiaTimothy P Stevens
Division of Neonatology, Department of Pediatrics, University of Rochester, Rochester, New York, USA
Pediatr Pulmonol 45:371-9. 2010..A possible explanation for these inconsistent findings is that the cumulative dosage of neonatal supplemental oxygen to which infants are exposure is difficult to accurately quantify...
- Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic herniaTimothy P Stevens
Department of Pediatrics, Division of Neonatology, University of Rochester, Rochester, New York, USA
Pediatrics 123:494-502. 2009....
- Survival in early- and late-term infants with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenationTimothy P Stevens
Division of Neonatology, Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, Rochester, New York 14642, USA
Pediatrics 110:590-6. 2002..Changes in survival rates of term infants and the factors associated with these changes were assessed over the 25 years that ECMO has been available...
- Cost-effectiveness analysis of palivizumab in premature infants without chronic lung diseaseNahed O Elhassan
Division of Neonatology, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA
Arch Pediatr Adolesc Med 160:1070-6. 2006....
- Controversies in palivizumab useTimothy P Stevens
Golisano Children s Hospital at Strong, University of Rochester Medical Center, Rochester, NY, USA
Pediatr Infect Dis J 23:1051-2. 2004
- Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomesCARL T D'ANGIO
Department of Pediatrics, Strong Children s Research Center, Golisano Children s Hospital at Strong, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Pediatrics 110:1094-102. 2002..To measure the primary and secondary school-age neurologic, cognitive, and educational outcomes in a cohort of extremely premature infants born after the introduction of exogenous surfactant therapy in a circumscribed region...
- Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States countiesKecia N Carroll
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
Pediatr Infect Dis J 31:e229-31. 2012..Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria...
- An evidence-based catheter bundle alters central venous catheter strategy in newborn infantsMeggan Butler-O'Hara
School of Nursing, University of Rochester, Rochester, NY, USA
J Pediatr 160:972-7.e2. 2012....
- Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trialAnn Reininger
Strong Children s Research Center, University of Rochester, Rochester, NY 14642, USA
J Perinatol 25:703-8. 2005....
- Surfactant replacement therapyTimothy P Stevens
Golisano Children s Hospital at Strong, University of Rochester, Rochester, NY, USA
Chest 131:1577-82. 2007..A specific CPT code for surfactant administration is scheduled to be introduced in 2007. This article reviews clinical issues in SRT and the practice management considerations necessary to provide this care...
- Vancomycin usage in central venous catheters in a neonatal intensive care unitNahed O Elhassan
Division of Neonatology, Golisano Children s Hospital at Strong, Rochester, NY, USA
Pediatr Infect Dis J 23:201-6. 2004..The use of vancomycin was reserved for documented infections with vancomycin-susceptible organisms...
- Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklistsJoseph Schulman
Weill Medical College, Cornell University, Pediatrics Newborn Medicine, 525 East 68th St, Box 106, New York, New York 10021, USA
Pediatrics 127:436-44. 2011..We sought to confirm whether adopting standardized bundles and using central-line maintenance checklists reduced central-line-associated bloodstream infections (CLABSI)...
- Infant race affects application of clinical guidelines when screening for drugs of abuse in newbornsMarc A Ellsworth
Strong Children s Research Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
Pediatrics 125:e1379-85. 2010..Established drug-screening criteria may be applied in a manner that considers nonproven risk factors such as race in addition to evidence-based factors...
- Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infantsShalu Narang
University of Rochester, Rochester, New York 14642, USA
Pediatr Blood Cancer 52:75-9. 2009..The objective of this study was to investigate the risk factors associated with catheter related thrombosis in very low birth weight (VLBW) infants...
- Development of a statewide collaborative to decrease NICU central line-associated bloodstream infectionsJ Schulman
Department of Pediatrics Newborn Medicine, Weill Cornell Medical College, Weill Cornell Medical Center, New York, NY, USA
J Perinatol 29:591-9. 2009....
- Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease?Nahed O Elhassan
Division of Neonatology, Department of Pediatrics, Strong Children s Research Center, University of Rochester, Rochester, NY, USA
Pediatr Infect Dis J 22:939-43. 2003..Multiple studies have been published that assess the risk of hospitalization for RSV disease by gestational age (GA) at birth and severity of lung disease...